1. Home
  2. OII vs STOK Comparison

OII vs STOK Comparison

Compare OII & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oceaneering International Inc.

OII

Oceaneering International Inc.

HOLD

Current Price

$34.00

Market Cap

2.3B

Sector

Energy

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$31.17

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OII
STOK
Founded
1964
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.0B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
OII
STOK
Price
$34.00
$31.17
Analyst Decision
Hold
Strong Buy
Analyst Count
4
10
Target Price
$31.33
$36.80
AVG Volume (30 Days)
1.4M
690.8K
Earning Date
04-22-2026
03-06-2026
Dividend Yield
N/A
N/A
EPS Growth
142.36
92.73
EPS
3.49
N/A
Revenue
$2,784,156,000.00
$184,420,000.00
Revenue This Year
$3.48
N/A
Revenue Next Year
$5.62
$74.28
P/E Ratio
$9.72
N/A
Revenue Growth
4.62
404.50
52 Week Low
$15.46
$5.35
52 Week High
$39.00
$40.22

Technical Indicators

Market Signals
Indicator
OII
STOK
Relative Strength Index (RSI) 49.65 39.74
Support Level $21.51 $20.33
Resistance Level $36.66 $35.75
Average True Range (ATR) 1.58 2.40
MACD -0.45 -0.65
Stochastic Oscillator 25.11 4.24

Price Performance

Historical Comparison
OII
STOK

About OII Oceaneering International Inc.

Oceaneering International Inc is a provider of engineered services and products and robotic solutions to the offshore energy, defense, aerospace, manufacturing, and entertainment industries. A majority of its products are produced for the offshore oil and gas market. The company's business segments are Integrity Management and Digital Solutions, Subsea Robotics, Manufactured Products, Offshore Projects Group, and Aerospace and Defense Technologies. Maximum revenue is generated from its Subsea Robotics segment, which provides remotely operated vehicles (ROVs) for drill support and vessel-based services, underwater surveys, tooling, and other activities. Geographically, the company derives its key revenue from the United States, followed by Africa, Norway, Brazil, and other regions.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: